The Therapeutic Principle of Combined Strengthening Qi and Eliminating Pathogens in Treating Middle-Advanced Primary Liver Cancer: A Systematic Review and Meta-Analysis
- 1School of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, China
- 2Department of Oncology, The First Affiliated Hospital, Guangxi University of Chinese Medicine, Nanning, China
- 3Department of Pharmacy, Sichuan Provincial Orthopedic Hospital, Chengdu, China
- 4Health Preservation and Rehabilitation College, Chengdu University of Traditional Chinese Medicine, Chengdu, China
- 5Department of Liver Disease, The First Affiliated Hospital, Guangxi University of Chinese Medicine, Nanning, China
- 6Pharmacy College, Chengdu University of Traditional Chinese Medicine, Chengdu, China
by She, Y., Huang, Q., Ye, Z., Hu, Y., Wu, M., Qin, K., Wei, A., Yang, X., Liu, Y., Zhang, C. and Ye, Q. (2021). Front. Pharmacol. 12:714287. doi: 10.3389/fphar.2021.714287
In the published article, there was an error in affiliation 2. Instead of “Department of Oncology, The First Affiliated Hospital, Guangxi University of Chinese Medicine, Chengdu, China”, it should be “Department of Oncology, The First Affiliated Hospital, Guangxi University of Chinese Medicine, Nanning, China”.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: Chinese medicinal formulas, transcatheter arterial chemoembolization, drastic medicinals, therapeutic principle, primary liver cancer, meta-analysis
Citation: She Y, Huang Q, Ye Z, Hu Y, Wu M, Qin K, Wei A, Yang X, Liu Y, Zhang C and Ye Q (2022) Corrigendum: The Therapeutic Principle of Combined Strengthening Qi and Eliminating Pathogens in Treating Middle-Advanced Primary Liver Cancer: A Systematic Review and Meta-Analysis. Front. Pharmacol. 13:846668. doi: 10.3389/fphar.2022.846668
Received: 31 December 2021; Accepted: 18 January 2022;
Published: 04 February 2022.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2022 She, Huang, Ye, Hu, Wu, Qin, Wei, Yang, Liu, Zhang and Ye. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Qiaobo Ye, eWVxaWFvYm9AY2R1dGNtLmVkdS5jbg==
†These authors contributed equally to this work